3 Ultra-High-Yield Dividend Stocks to Buy in August (1 Yields Over 13.5%)

The article promotes three ultra-high-yield income stocks: AGNC Investment yielding over 13.5% (75 straight months of dividends), Ares Capital nearing a 10% yield (17 straight years of stable/growing payouts), and Western Midstream yielding almost 8% (distribution up ~193% since its 2020 reset). It argues the payouts are supported by leverage-assisted MBS returns for AGNC, underwriting performance and excess taxable income carried forward for ARCC, and long-term fixed-rate contracts plus $2.1B–$2.3B distributable cash flow for WES. Overall, the news is a constructive income-pick list with modest informational impact, but highlights elevated risk due to leverage and credit exposure.

Analysis

This is less a “high yield” theme than a quality screen inside income assets. AGNC is effectively a leveraged duration bet: the dividend can survive while total return still disappoints if book value keeps leaking from rate volatility or mortgage spread widening. ARCC and WES are structurally better cash-flow stories because their payouts are supported by operating assets, not mostly by balance-sheet spread management; that should continue to pull capital away from lower-conviction yield products if investors stay defensive.

The second-order winner is the broader “durable income” complex: higher-quality BDCs, midstream names, and possibly preferreds should capture flows from yield seekers who want less mark-to-market risk. The loser is any levered income vehicle where the headline yield masks dependence on funding conditions or capital-market access. In that framework, AGNC has the most convex downside over 1-3 months if rates back up, while WES has the cleanest 6-18 month path as long as volumes and acquisition discipline hold.

Contrarian view: the market may be underestimating how fast a dividend can become a value trap when the yield is the only visible feature. A maintained payout does not equal a good stock if NAV erosion or credit normalization is eating equity value underneath. The real falsifier for AGNC is stabilization in book value and mortgage spreads; for ARCC, it is a visible pickup in nonaccruals; for WES, it is slowing DCF growth or leverage drifting higher after acquisitions.

Key Decisions for Investors

• Long WES vs short AGNC, sized as a relative-value pair for 1-3 months; thesis is that contract-backed cash flow will outperform a levered MBS proxy if rates stay rangebound or volatile. Risk/reward: target 8-12% relative outperformance; stop if 10Y Treasury drops sharply and AGNC book value stabilizes.
• Overweight ARCC on pullbacks for a 6-12 month horizon; use it as the cleaner private-credit yield vehicle versus lower-quality BDCs. Risk/reward: modest upside from durable dividend support, but cut exposure if nonaccruals or realized losses begin trending higher.
• Underweight or avoid initiating new AGNC exposure until the next book-value update confirms spreads are improving; the yield is compensating for balance-sheet risk, not a free premium. Falsifier: a sustained rally in MBS prices and lower repo/funding costs.
• If forced into an income basket, prefer WES/ARCC over AGNC for fresh capital; use any AGNC-driven yield chase only tactically, not as a core hold. Entry timing: wait for a rate-volatility spike to fade before considering WES add-ons.